Equivalency of tricyclic antidepressants in open-label neuropathic pain study

Acta Neurologica Scandinavica

Volumn 129, Issue 2, 2014, Pages 132-141

  Liu, W Q ^a   Kanungo, A ^a   Toth, C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Chronic pain C10.597.617.258; Polyneuropathy C10.668.829.800; Tricyclic antidepressants D27.505.954.427.700.122.055

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CODEINE; FENTANYL; MORPHINE; NABILONE; NORTRIPTYLINE; OXYCODONE; PARACETAMOL; PHENYTOIN; VALPROIC ACID;

ADULT; ANALGESIA; ANXIETY DISORDER; ARTICLE; BRIEF PAIN INVENTORY; DISABILITY; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HEART RATE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MOOD; NAUSEA; NEUROPATHIC PAIN; OBESITY; OPEN STUDY; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SHORT FORM 36; SLEEP; TERTIARY HEALTH CARE; URINARY HESITANCY; VISUAL ANALOG SCALE; WEIGHT GAIN; XEROSTOMIA; YOUNG ADULT;

CHRONIC PAIN C10.597.617.258; POLYNEUROPATHY C10.668.829.800; TRICYCLIC ANTIDEPRESSANTS D27.505.954.427.700.122.055;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; NORTRIPTYLINE; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 84891910566     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12169     Document Type: Article

References (18)

1. Pain IAftSo. IASP Taxonomy. International Association for the Study of Pain. 2012; http://www.iasp-pain.org/Content/NavigationMenu/GeneralResourceLinks/PainDefinitions/default.htm#Neuropathicpain. (accessed 12 April 2012).
2. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380-7.
3. Toth C, Au S. A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy. Pain 2008;138:657-66.
4. Poliakov I, Toth C. The impact of pain in patients with polyneuropathy. Eur J Pain 2011;15:1015-22.
5. Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12:13-21.
6. Bril V, England J, Franklin GM et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758-65.
7. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001;26:21-9.
8. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51:1166-71.
9. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
10. Max MB, Culnane M, Schafer SC et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96.
11. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009;374:1252-61.
12. Bestard JA, Toth CC. An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy. Pain Pract 2011;11:353-68.
13. Bouhassira D, Attal N, Alchaar H et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36.
14. Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998;51:945-52.
15. Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol 2001;19:697-702.
16. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992;48:29-36.
17. Barbui C, Hotopf M. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiatry 2001;178:129-44.
18. Wolff RF, Bala MM, Westwood M, Kessels AG, Kleijnen J. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand 2011;123:295-309.